Trends in GLP-1 Receptor Agonist and SGLT2-Inhibitor Utilization and Expenditure Between 2017–2023: Demographic, Income, and Insurance Associations
Crossref DOI link: https://doi.org/10.1007/s11606-026-10408-4
Published Online: 2026-04-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jacobs, Molly https://orcid.org/0000-0001-5943-8507
Fang, Qianqian
Ellis, Charles
Text and Data Mining valid from 2026-04-15
Version of Record valid from 2026-04-15
Article History
Received: 15 December 2025
Accepted: 30 March 2026
First Online: 15 April 2026
Declarations
:
: The authors declare that they do not have a conflict of interest.